BNB Plus

BNB Plus EBITDA per Share

The EBITDA per Share of BNB Plus (BNBX) as of Oct 21, 2026 is -1.79 USD. In the previous year, EBITDA per Share was -333.92 USD — a change of -99.46% (higher).

EBITDA per Share

-1.79USD

YoY

-99.46%

Last updated:

EBITDA per Share of BNB Plus is 2025 -1.79 USD. EBITDA per Share of BNB Plus was 2024 -333.92 USD. It decreases by -99.46% higher compared to the previous year.

The BNB Plus EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
-110,980.00 USD
Jan 1, 2019
-87,350.00 USD
Jan 1, 2020
-40,830.00 USD
Jan 1, 2021
-1.28 USD
Jan 1, 2022
-1.43 USD
Jan 1, 2023
-1.13 USD
Jan 1, 2024
-333.92 USD
Jan 1, 2025
-1.79 USD
The BNB Plus EBITDA per Share history
YEAREBITDA per ShareYoY
-1.79USD-99.46%
-333.92USD+29,580.04%
-1.13USD-21.59%
-1.43USD+11.72%
-1.28USD-100.00%
-40,830.00USD-53.26%
-87,350.00USD-21.29%
-110,980.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BNB Plus Stock analysis

What does BNB Plus do? BNB Plus Corp generates revenue through its SigNature DNA platform, which serves as the core ingredient for all security solutions. The company sells SigNature DNA, SigNature T DNA for textile authentication, and DNAnet for forensic evidence linking. Its SigNify IF portable DNA reader enables real-time field authentication, targeting supply chain integrity. Customers include forensic agencies, law enforcement, and textile manufacturers seeking anti-counterfeiting and evidence verification solutions. The firm's products are used across multiple segments: SigNature T DNA specifically targets the apparel industry for tagging and authentication, while DNAnet supports crime scene investigations and property recovery. SigNify IF provides mobile forensic capabilities, appealing to law enforcement and security professionals requiring on-site DNA verification. All solutions leverage the company's proprietary DNA sequencing technology developed through PCR-based production. Applied DNA Sciences, Inc. markets its DNA-based security products under the SigNature DNA, SigNify, and DNAnet brands. The company's technology platform includes fiberTyping and digitalDNA, which complement its core offerings. These products are sold to clients needing forensic authentication, supply chain protection, and anti-counterfeiting measures, with applications spanning textiles, law enforcement, and property recovery sectors. BNB Plus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BNB Plus stock

EBITDA per Share of BNB Plus is -1.79 USD in 2025.

EBITDA per Share of BNB Plus changed from -333.92 USD to -1.79 USD, representing a -99.46% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share BNB Plus since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — BNB Plus

All Key Metrics — BNB Plus